What is she best known for?
The fields of study she is best known for:
- Cancer
- Internal medicine
- Gene
Internal medicine, Breast cancer, Oncology, Surgery and Trastuzumab are her primary areas of study.
Her Breast cancer research includes themes of Gynecology and Adjuvant therapy.
Her studies in Oncology integrate themes in fields like Cancer, Survival rate, Estrogen receptor, Hazard ratio and Survival analysis.
Her Surgery study combines topics from a wide range of disciplines, such as Epidermoid carcinoma, Clinical trial, Metastasis and Cohort study.
Her Trastuzumab study combines topics in areas such as Ejection fraction, Urology, Cyclophosphamide, Paclitaxel and Fluorouracil.
Vera J. Suman has included themes like Pertuzumab, Regimen, Lapatinib and Trastuzumab emtansine in her Paclitaxel study.
Her most cited work include:
- Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer (4382 citations)
- Whole-genome analysis informs breast cancer response to aromatase inhibition (782 citations)
- Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer: The ACOSOG Z1071 (Alliance) Clinical Trial (685 citations)
What are the main themes of her work throughout her whole career to date?
Vera J. Suman focuses on Internal medicine, Breast cancer, Oncology, Surgery and Cancer.
Her Internal medicine research incorporates elements of Gastroenterology and Endocrinology.
The concepts of her Breast cancer study are interwoven with issues in Cancer research and Gynecology.
Her research investigates the connection between Oncology and topics such as Letrozole that intersect with issues in Exemestane.
Her study in Surgery is interdisciplinary in nature, drawing from both Melanoma and Urology.
The various areas that she examines in her Trastuzumab study include Cyclophosphamide and Paclitaxel.
She most often published in these fields:
- Internal medicine (53.89%)
- Breast cancer (40.42%)
- Oncology (38.62%)
What were the highlights of her more recent work (between 2015-2021)?
- Internal medicine (53.89%)
- Breast cancer (40.42%)
- Oncology (38.62%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Breast cancer, Oncology, Cancer research and Cancer.
Her Endocrinology research extends to the thematically linked field of Internal medicine.
Her research in Breast cancer intersects with topics in Alisertib, Immune system and Chemotherapy.
She has researched Oncology in several fields, including Clinical trial, Phases of clinical research, Anastrozole, Disease and Multiple myeloma.
Her biological study spans a wide range of topics, including Estrogen receptor beta, Metastasis, Bevacizumab, Triple-negative breast cancer and Estrogen receptor alpha.
Vera J. Suman combines subjects such as Biomarker and Precision medicine with her study of Cancer.
Between 2015 and 2021, her most popular works were:
- Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance) (120 citations)
- Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers (49 citations)
- DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine (47 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Vera J. Suman mostly deals with Breast cancer, Internal medicine, Oncology, Cancer research and Cancer.
Her studies deal with areas such as Tumor microenvironment, Alisertib and Pathology as well as Breast cancer.
Her research integrates issues of Gastroenterology, Endocrinology and Stem cell in her study of Internal medicine.
The Oncology study combines topics in areas such as Immune system, Thalidomide, Chemotherapy and Lenalidomide.
Her Cancer research research includes elements of Immunology, Gene, Metastasis, Triple-negative breast cancer and Estrogen receptor alpha.
Her work deals with themes such as DNMT3B and Decitabine, which intersect with Cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
